Session Details
[O3]Oral Presentations 3
Tue. Jul 7, 2026 3:10 PM - 4:13 PM JST
Tue. Jul 7, 2026 6:10 AM - 7:13 AM UTC
Tue. Jul 7, 2026 6:10 AM - 7:13 AM UTC
Ito Hall( Ito International Research Center B2)
Chair:Tomohisa Okamura, Sho Ohta
[O3-01]Noncanonical Translation of Pathogen-Derived mRNAs and Its Regulation by Ribosome Quality Control (RQC)
*Toshifumi Inada1 (1. Division of RNA and gene regulation The Institute of Medical Science, The University of Tokyo (Japan))
[O3-02]Analysis of stress-responsive signaling pathways triggered by mRNA vaccines
*Mutsuhiro Takekawa1 (1. Division of Cell Signaling and Molecular Medicine, Institute of Medical Science, The University of Tokyo (Japan))
[O3-03]The role of novel age-associated ThA cells in the pathogenesis of systemic lupus erythematosus
*Tomohisa Okamura1, Hiroyuki Teruya2, Manaka Goto1, Keishi Fujio2 (1. Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine, The University of Tokyo (Japan), 2. Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo (Japan))
[O3-04]Antiviral defense by the epidermal stem cell system
*Emi K. Nishimura1 (1. Division of Aging and Rengeration, IMSUT (Japan))
[O3-05]Virus research using human lung organoids
*Kazuo Takayama1,2 (1. Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo (Japan), 2. Department of State-of-the-art and International Medicine, Graduate School of Medicine, Kyoto University (Japan))
[O3-06]Exploring Functionally Uncharacterized Phage Genes That Overcome Bacterial Anti-Phage Defense Systems
*Kotaro Kiga1 (1. Department of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan))
[O3-07]MUC19, as a novel genetic factor for severe COVID-19 in East Asians
*Genta Nagao1,2, Chifune Kai3, Takanori Asakura2, Koichi Fukunaga2, Ho Namkoong2, Yukinori Okada1,3,4 (1. The University of Tokyo (Japan), 2. Keio University (Japan), 3. The University of Osaka (Japan), 4. RIKEN Center (Japan))
[O3-08]Development and Evaluation of a Next-Generation AAV Vector-Based Nucleic Acid Vaccine Platform
*Takashi OKADA1 (1. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo (Japan))
[O3-09]Generating Mouse Models to Study OSKM Reprogramming and Immune Cell Epigenetics
*Sho Ohta1, Yasuhiro Yamada1 (1. Graduate School of Medicine, The University of Tokyo (Japan))
